Madison Investment Advisors LLC Makes New $6.73 Million Investment in HealthEquity, Inc. (NASDAQ:HQY)

Madison Investment Advisors LLC acquired a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 70,155 shares of the company's stock, valued at approximately $6,731,000. Madison Investment Advisors LLC owned about 0.08% of HealthEquity as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity during the 4th quarter valued at $26,000. Smartleaf Asset Management LLC raised its stake in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after acquiring an additional 98 shares during the period. Proficio Capital Partners LLC purchased a new stake in HealthEquity during the fourth quarter valued at about $39,000. UMB Bank n.a. boosted its position in HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after purchasing an additional 164 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ increased its stake in shares of HealthEquity by 1,934.8% in the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock worth $45,000 after purchasing an additional 445 shares in the last quarter. Institutional investors own 99.55% of the company's stock.

HealthEquity Price Performance

Shares of NASDAQ:HQY traded up $0.95 during trading on Tuesday, reaching $101.67. The company had a trading volume of 2,034,283 shares, compared to its average volume of 661,432. The company has a fifty day moving average of $105.76 and a two-hundred day moving average of $95.51. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $8.81 billion, a P/E ratio of 93.28, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59.

Remove Ads

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, March 18th. The company reported $0.55 EPS for the quarter, missing analysts' consensus estimates of $0.71 by ($0.16). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. Equities research analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insider Activity at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.20% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts recently commented on HQY shares. Wells Fargo & Company upped their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. Raymond James raised their price target on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Tuesday, February 25th. Barrington Research reiterated an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a research note on Friday. Royal Bank of Canada raised their target price on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research note on Tuesday, December 10th. Finally, Mizuho began coverage on HealthEquity in a report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 target price for the company. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $112.92.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.